Log in

NASDAQ:CLDXCelldex Therapeutics Insider Trades

$13.38
+0.38 (+2.92 %)
(As of 07/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$12.50
Now: $13.38▼
$13.50
50-Day Range
$2.26
MA: $5.60▼
$13.41
52-Week Range
$1.50
Now: $13.38▼
$13.91
Volume942,728 shs
Average Volume1.54 million shs
Market Capitalization$301.79 million
P/E RatioN/A
Dividend YieldN/A
Beta3.07

Insider Trades

Celldex Therapeutics (NASDAQ:CLDX) Insider Buying and Selling Activity

Insider Ownership Percentage: 2.40%

Insider Buying and Selling by Quarter


Celldex Therapeutics (NASDAQ CLDX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/11/2020Diane C YoungSVPBuy2,115$4.73$10,003.952,115  
6/9/2020Anthony S. MarucciCEOBuy15,000$2.99$44,850.00  
6/9/2020James J MarinoDirectorBuy8,305$2.99$24,831.9512,704  
6/9/2020Margo Heath-ChiozziSVPBuy1,000$2.99$2,990.001,000  
6/9/2020Samuel Bates MartinCFOBuy9,750$2.99$29,152.50  
6/9/2020Tibor KelerVPBuy5,000$2.99$14,950.007,357  
8/24/2018James J MarinoDirectorBuy40,000$0.48$19,200.0065,997  
6/15/2018Tibor KelerVPBuy16,500$0.59$9,735.0035,368  
9/2/2016Tibor KelerVPBuy3,000$3.32$9,960.0018,868  
11/23/2015Avery W. CatlinCFOSell25,000$18.00$450,000.0035,109  
8/25/2015Larry EllbergerDirectorBuy5,000$14.00$70,000.0053,500  
8/20/2015Larry EllbergerDirectorBuy5,000$15.00$75,000.0048,500  
8/18/2015Larry EllbergerDirectorBuy5,000$15.95$79,750.0043,500  
8/13/2015Anthony S MarucciCEOBuy5,800$16.81$97,498.00  
8/13/2015Larry EllbergerDirectorBuy5,000$16.59$82,950.00  
6/15/2015Avery W CatlinCFOSell25,000$24.59$614,750.00  
12/6/2013Avery CatlinCFOSell183,333$24.50$4,491,658.5014,109  
12/6/2013Larry EllbergerDirectorSell17,728$24.50$434,336.0025,000  
(Data available from 1/1/2013 forward)
This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.